Phase II Study of Trastuzumab (Herceptin) and Capecitabine (Xeloda) in Women With Taxanes and Anthracyclines Refractory Metastatic Breast Cancer and HER2 Over-Expression.
Phase of Trial: Phase II
Latest Information Update: 21 May 2013
At a glance
- Drugs Capecitabine (Primary) ; Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 Nov 2008 Status changed from active, no longer recruiting to completed.
- 30 Aug 2005 New trial record.